Integrated BioPharma, Inc. (OTCMKTS:INBP) Short Interest Update

Integrated BioPharma, Inc. (OTCMKTS:INBP) was the target of a significant drop in short interest in the month of February. As of February 28th, there was short interest totalling 300 shares, a drop of 25.0% from the February 13th total of 400 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 32,600 shares, the days-to-cover ratio is currently 0.0 days.

Integrated BioPharma Price Performance

Shares of OTCMKTS INBP opened at $0.32 on Tuesday. The stock has a market capitalization of $9.60 million, a P/E ratio of 10.57 and a beta of 0.89. The company has a 50-day moving average price of $0.34 and a 200-day moving average price of $0.30. Integrated BioPharma has a 1 year low of $0.16 and a 1 year high of $0.42.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.